TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial on the Effects of Mediterranean Diet (Rich on Olive Oil) in the Reduction of Coronary Events of Patients With Coronary Disease
Brief Summary: The purpose of this study is to compare the effects of the consumption of two different dietary patterns (low fat versus Mediterranean Diet) on the incidence of cardiovascular events of persons with coronary disease.


Options:
A: Arm Label: Insulin glargine + omega-3 polyunsaturated fatty acids; Type: EXPERIMENTAL; Interventions: Drug: insulin glargine (HOE901), Drug: omega-3 polyunsaturated fatty acids (PUFA), Device: reusable pen device for insulin injection | Arm Label: Insulin glargine + placebo; Type: EXPERIMENTAL; Interventions: Drug: insulin glargine (HOE901), Drug: placebo, Device: reusable pen device for insulin injection | Arm Label: Standard care + omega-3 polyunsaturated fatty acids; Type: EXPERIMENTAL; Interventions: Drug: omega-3 polyunsaturated fatty acids (PUFA) | Arm Label: Standard care + placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: insulin glargine (HOE901); Assigned to Arm(s): Insulin glargine + omega-3 polyunsaturated fatty acids, Insulin glargine + placebo | Intervention Type: DRUG; Name: omega-3 polyunsaturated fatty acids (PUFA); Assigned to Arm(s): Insulin glargine + omega-3 polyunsaturated fatty acids, Standard care + omega-3 polyunsaturated fatty acids | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Insulin glargine + placebo, Standard care + placebo | Intervention Type: DEVICE; Name: reusable pen device for insulin injection; Assigned to Arm(s): Insulin glargine + omega-3 polyunsaturated fatty acids, Insulin glargine + placebo
B: Arm Label: Low Carb; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low- Carbohydrate -Atkins Diet | Arm Label: Low Calorie; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low Calorie Diet | Intervention Type: BEHAVIORAL; Name: Low- Carbohydrate -Atkins Diet; Assigned to Arm(s): Low Carb | Intervention Type: BEHAVIORAL; Name: Low Calorie Diet; Assigned to Arm(s): Low Calorie
C: Arm Label: Low Fat Diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low Fat Diet | Arm Label: Mediterranean Diet; Type: EXPERIMENTAL; Interventions: Behavioral: Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: Mediterranean Diet; Assigned to Arm(s): Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: Low Fat Diet; Assigned to Arm(s): Low Fat Diet
D: Intervention Type: BEHAVIORAL; Name: Four Diets Differing in Macronutrient Composition; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Diets Low in Saturated Fat; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial on the Effects of Mediterranean Diet (Rich on Olive Oil) in the Reduction of Coronary Events of Patients With Coronary Disease
Brief Summary: The purpose of this study is to compare the effects of the consumption of two different dietary patterns (low fat versus Mediterranean Diet) on the incidence of cardiovascular events of persons with coronary disease.


Options:
A: Arm Label: Mediterranean Diet Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Mediterranean diet Intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mediterranean diet Intervention; Assigned to Arm(s): Mediterranean Diet Intervention group
B: Arm Label: Experimental diet; Type: EXPERIMENTAL; Interventions: Other: Experimental diet | Arm Label: Control diet; Type: ACTIVE_COMPARATOR; Interventions: Other: Control diet | Intervention Type: OTHER; Name: Experimental diet; Assigned to Arm(s): Experimental diet | Intervention Type: OTHER; Name: Control diet; Assigned to Arm(s): Control diet
C: Arm Label: BALANCE group; Type: EXPERIMENTAL; Interventions: Behavioral: BALANCE | Arm Label: Control Diet group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control diet | Intervention Type: BEHAVIORAL; Name: BALANCE; Assigned to Arm(s): BALANCE group | Intervention Type: BEHAVIORAL; Name: Control diet; Assigned to Arm(s): Control Diet group
D: Arm Label: Low Fat Diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low Fat Diet | Arm Label: Mediterranean Diet; Type: EXPERIMENTAL; Interventions: Behavioral: Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: Mediterranean Diet; Assigned to Arm(s): Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: Low Fat Diet; Assigned to Arm(s): Low Fat Diet

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: OPEN-LABEL SAFETY AND EFFICACY EVALUATION OF FX-1006A IN SUBJECTS WITH TRANSTHYRETIN (TTR) AMYLOIDOSIS
Brief Summary: This is a Phase 3, open-label study designed to obtain additional long-term safety and efficacy data for oral tafamidis (20 mg soft gelatin capsule) administered once daily (QD). In addition, this study continued to provide tafamidis to Val30Met subjects who had completed Protocol Fx-006 (a 1-year, open-label extension study to Protocol Fx-005 which was a randomized, double-blind, placebo-controlled, 18-month study to evaluate the safety and efficacy of tafamidis) or non-Val30Met subjects who had completed Protocol Fx1A-201 (a Phase 2, open-label study to evaluate TTR stabilization, safety, and tolerability of tafamidis) for up to 10 years or until subjects had access to tafamidis for ATTR-PN via prescription. Upon regulatory approval for the treatment of ATTR-PN in their respective country and access to prescription tafamidis, subjects may have been withdrawn from the study. Such subjects were considered study completers.


Options:
A: Arm Label: patisiran (ALN-TTR02); Type: ACTIVE_COMPARATOR; Interventions: Drug: patisiran (ALN-TTR02) | Arm Label: Sterile Normal Saline (0.9% NaCl); Type: PLACEBO_COMPARATOR; Interventions: Drug: Sterile Normal Saline (0.9% NaCl) | Intervention Type: DRUG; Name: patisiran (ALN-TTR02); Assigned to Arm(s): patisiran (ALN-TTR02) | Intervention Type: DRUG; Name: Sterile Normal Saline (0.9% NaCl); Assigned to Arm(s): Sterile Normal Saline (0.9% NaCl)
B: Arm Label: Inotersen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Inotersen | Arm Label: Placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Inotersen; Assigned to Arm(s): Inotersen | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Open-Label; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tafamidis | Intervention Type: DRUG; Name: Tafamidis; Assigned to Arm(s): Open-Label
D: Arm Label: Fx-1006A; Type: EXPERIMENTAL; Interventions: Drug: Fx-1006A | Intervention Type: DRUG; Name: Fx-1006A; Assigned to Arm(s): Fx-1006A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: THE FEASIBILITY OF PATIENT SELF-MANAGEMENT OF WARFARIN THERAPY IN THE CANADIAN PRIMARY CARE SETTING
Brief Summary: Atrial Fibrillation is a heart condition in which people are treated with blood thinners such as warfarin to decrease the risk of stroke. Large studies have shown that when patients adjust their own dose of warfarin, similar to insulin, results are better.

The purpose of this study is to evaluate whether implementing this method of warfarin management is beneficial in a Canadian primary care clinic. Patients will be educated on how to adjust their own warfarin doses when necessary using simple charts. The success of patient self management will be compared against management by a physician.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: SBAR | Intervention Type: OTHER; Name: SBAR; Assigned to Arm(s): 2
B: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: Medication Education Tool | Intervention Type: OTHER; Name: Medication Education Tool; Assigned to Arm(s): 2
C: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Drug: Warfarin | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Drug: Warfarin | Intervention Type: DRUG; Name: Warfarin; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: Warfarin; Assigned to Arm(s): Group B
D: Arm Label: AF Clinic; Type: EXPERIMENTAL; Interventions: Other: AF Clinic | Arm Label: Care as Usual; Type: ACTIVE_COMPARATOR; Interventions: Other: Care as Usual | Intervention Type: OTHER; Name: AF Clinic; Assigned to Arm(s): AF Clinic | Intervention Type: OTHER; Name: Care as Usual; Assigned to Arm(s): Care as Usual

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: THE FEASIBILITY OF PATIENT SELF-MANAGEMENT OF WARFARIN THERAPY IN THE CANADIAN PRIMARY CARE SETTING
Brief Summary: Atrial Fibrillation is a heart condition in which people are treated with blood thinners such as warfarin to decrease the risk of stroke. Large studies have shown that when patients adjust their own dose of warfarin, similar to insulin, results are better.

The purpose of this study is to evaluate whether implementing this method of warfarin management is beneficial in a Canadian primary care clinic. Patients will be educated on how to adjust their own warfarin doses when necessary using simple charts. The success of patient self management will be compared against management by a physician.


Options:
A: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Self-management; Type: EXPERIMENTAL; Interventions: Other: Self-monitoring and adjustment of oral anticoagulation | Intervention Type: OTHER; Name: Self-monitoring and adjustment of oral anticoagulation; Assigned to Arm(s): Self-management
B: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Drug: Warfarin | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Drug: Warfarin | Intervention Type: DRUG; Name: Warfarin; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: Warfarin; Assigned to Arm(s): Group B
C: Arm Label: Dabigatran etexilate; Type: EXPERIMENTAL; Interventions: Drug: dabigatran etexilate intermediate dose, Drug: dabigatran etexilate low dose, Drug: dabigatran etexilate high dose | Arm Label: warfarin; Type: ACTIVE_COMPARATOR; Interventions: Drug: warfarin 1mg, Drug: warfarin 5mg, Drug: warfarin 3mg | Intervention Type: DRUG; Name: warfarin 1mg; Assigned to Arm(s): warfarin | Intervention Type: DRUG; Name: dabigatran etexilate intermediate dose; Assigned to Arm(s): Dabigatran etexilate | Intervention Type: DRUG; Name: dabigatran etexilate low dose; Assigned to Arm(s): Dabigatran etexilate | Intervention Type: DRUG; Name: warfarin 5mg; Assigned to Arm(s): warfarin | Intervention Type: DRUG; Name: dabigatran etexilate high dose; Assigned to Arm(s): Dabigatran etexilate | Intervention Type: DRUG; Name: warfarin 3mg; Assigned to Arm(s): warfarin
D: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Weekly patient self-testing of prothrombin time | Arm Label: Arm 2; Type: OTHER; Interventions: Other: High quality anticoagulation management (HQACM) with conventional monthly testing | Intervention Type: PROCEDURE; Name: Weekly patient self-testing of prothrombin time; Assigned to Arm(s): Arm 1 | Intervention Type: OTHER; Name: High quality anticoagulation management (HQACM) with conventional monthly testing; Assigned to Arm(s): Arm 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Maintenance Schedules Following Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease
Brief Summary: Chronic obstructive pulmonary disease (COPD), a preventable and treatable condition, is a major healthcare problem with huge human and economic costs. It affects 3 million people, results in 1.4 million consultations, causes 30,000 deaths, and costs £800M per year in the UK. Considerable research expenditure is devoted to finding new and expensive interventions. However pulmonary rehabilitation (PR) is an available therapeutic option with good evidence of benefit for patients in terms of quality of life and daily functioning.

The primary objective of the study is to evaluate the effectiveness and cost effectiveness of the addition of a maintenance programme following pulmonary rehabilitation in patients with COPD when compared to standard care.

The secondary objective is to identify baseline characteristics that will predict improvement in pulmonary rehabilitation programmes and adherence to maintenance strategies. By measuring a series of demographic, clinical, physiological, psychological and biochemical parameters the researchers hope to be able to predict those patients who are likely to receive the greatest benefit from pulmonary rehabilitation.

An additional objective will be to prepare a detailed maintenance programme manual. This will be available to other centres providing pulmonary rehabilitation at the conclusion of the study


Options:
A: Arm Label: Pulmonary Rehabilitation Group; Type: EXPERIMENTAL; Interventions: Behavioral: Pulmonary Intervention | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pulmonary Intervention; Assigned to Arm(s): Pulmonary Rehabilitation Group
B: Arm Label: Group A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Support, management, educational, counselling, follow-up | Arm Label: Group B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Support, management, educational, counselling, follow-up | Arm Label: Group C; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Support, management, educational, counselling, follow-up; Assigned to Arm(s): Group A, Group B
C: Arm Label: Care pathway teams.; Type: EXPERIMENTAL; Interventions: Behavioral: Care pathway. | Arm Label: Usual care teams.; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Care pathway.; Assigned to Arm(s): Care pathway teams.
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Home based pulmonary rehabilitation with exercise | Arm Label: exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: Home based pulmonary rehabilitation with exercise | Intervention Type: OTHER; Name: Home based pulmonary rehabilitation with exercise; Assigned to Arm(s): Placebo, exercise

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Controlled Trial of Mental Health Interventions for Common Mental Health Problems Experienced by Torture Survivors Living in Kurdistan, Iraq.
Brief Summary: The purpose of this study is to determine the relative effectiveness of three different mental health counseling interventions in the treatment of mental health problems commonly affecting torture and trauma survivors living in Kurdistan, Iraq.


Options:
A: Arm Label: Components-Based Interventions (CBI); Type: EXPERIMENTAL; Interventions: Other: Components-Based Intervention | Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Other: Cognitive Processing Therapy | Arm Label: Wait List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy | Intervention Type: OTHER; Name: Components-Based Intervention; Assigned to Arm(s): Components-Based Interventions (CBI)
B: Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: Behavioral Activation; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Activation | Arm Label: non-specific counseling; Type: EXPERIMENTAL; Interventions: Behavioral: nonspecific counseling | Arm Label: wait control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Behavioral Activation; Assigned to Arm(s): Behavioral Activation | Intervention Type: BEHAVIORAL; Name: nonspecific counseling; Assigned to Arm(s): non-specific counseling
C: Arm Label: Mind-Body Skills Groups; Type: EXPERIMENTAL; Interventions: Behavioral: Mind-Body Skills Groups | Arm Label: Delayed Intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mind-Body Skills Groups; Assigned to Arm(s): Mind-Body Skills Groups
D: Arm Label: Psychosocial counseling; Type: N/A; Interventions: N/A | Arm Label: Medication; Type: N/A; Interventions: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Controlled Trial of Mental Health Interventions for Common Mental Health Problems Experienced by Torture Survivors Living in Kurdistan, Iraq.
Brief Summary: The purpose of this study is to determine the relative effectiveness of three different mental health counseling interventions in the treatment of mental health problems commonly affecting torture and trauma survivors living in Kurdistan, Iraq.


Options:
A: Arm Label: Components-Based Interventions (CBI); Type: EXPERIMENTAL; Interventions: Other: Components-Based Intervention | Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Other: Cognitive Processing Therapy | Arm Label: Wait List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy | Intervention Type: OTHER; Name: Components-Based Intervention; Assigned to Arm(s): Components-Based Interventions (CBI)
B: Arm Label: BF-CBT and group physiotherapy; Type: EXPERIMENTAL; Interventions: Behavioral: BF-CBT and group physiotherapy | Arm Label: Waiting list; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: BF-CBT and group physiotherapy | Intervention Type: BEHAVIORAL; Name: BF-CBT and group physiotherapy; Assigned to Arm(s): BF-CBT and group physiotherapy, Waiting list
C: Arm Label: Waitlist-Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Common Elements Treatment Approach; Type: EXPERIMENTAL; Interventions: Behavioral: Common Elements Treatment Approach | Intervention Type: BEHAVIORAL; Name: Common Elements Treatment Approach; Assigned to Arm(s): Common Elements Treatment Approach
D: Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: Behavioral Activation; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Activation | Arm Label: non-specific counseling; Type: EXPERIMENTAL; Interventions: Behavioral: nonspecific counseling | Arm Label: wait control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Behavioral Activation; Assigned to Arm(s): Behavioral Activation | Intervention Type: BEHAVIORAL; Name: nonspecific counseling; Assigned to Arm(s): non-specific counseling

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Controlled Trial of Mental Health Interventions for Common Mental Health Problems Experienced by Torture Survivors Living in Kurdistan, Iraq.
Brief Summary: The purpose of this study is to determine the relative effectiveness of three different mental health counseling interventions in the treatment of mental health problems commonly affecting torture and trauma survivors living in Kurdistan, Iraq.


Options:
A: Arm Label: eMotion intervention; Type: EXPERIMENTAL; Interventions: Behavioral: eMotion | Arm Label: Waiting list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: eMotion; Assigned to Arm(s): eMotion intervention
B: Arm Label: Telepsychology; Type: EXPERIMENTAL; Interventions: Behavioral: Telepsychology | Arm Label: Face-to-face therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Face-to-face therapy | Intervention Type: BEHAVIORAL; Name: Telepsychology; Assigned to Arm(s): Telepsychology | Intervention Type: BEHAVIORAL; Name: Face-to-face therapy; Assigned to Arm(s): Face-to-face therapy
C: Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: Behavioral Activation; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Activation | Arm Label: non-specific counseling; Type: EXPERIMENTAL; Interventions: Behavioral: nonspecific counseling | Arm Label: wait control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Behavioral Activation; Assigned to Arm(s): Behavioral Activation | Intervention Type: BEHAVIORAL; Name: nonspecific counseling; Assigned to Arm(s): non-specific counseling
D: Arm Label: Smartphone delivered BA; Type: EXPERIMENTAL; Interventions: Behavioral: Smartphone delivered BA | Arm Label: Smartphone delivered mindfulness; Type: ACTIVE_COMPARATOR; Interventions: Other: Smartphone delivered mindfulness | Intervention Type: BEHAVIORAL; Name: Smartphone delivered BA; Assigned to Arm(s): Smartphone delivered BA | Intervention Type: OTHER; Name: Smartphone delivered mindfulness; Assigned to Arm(s): Smartphone delivered mindfulness

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Controlled Trial of Mental Health Interventions for Common Mental Health Problems Experienced by Torture Survivors Living in Kurdistan, Iraq.
Brief Summary: The purpose of this study is to determine the relative effectiveness of three different mental health counseling interventions in the treatment of mental health problems commonly affecting torture and trauma survivors living in Kurdistan, Iraq.


Options:
A: Arm Label: Waitlist-Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Common Elements Treatment Approach; Type: EXPERIMENTAL; Interventions: Behavioral: Common Elements Treatment Approach | Intervention Type: BEHAVIORAL; Name: Common Elements Treatment Approach; Assigned to Arm(s): Common Elements Treatment Approach
B: Arm Label: Self Help Plus; Type: EXPERIMENTAL; Interventions: Behavioral: Self Help Plus | Arm Label: Enhanced Treatment As Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self Help Plus; Assigned to Arm(s): Self Help Plus
C: Arm Label: Technology Arm; Type: EXPERIMENTAL; Interventions: Other: Avatar assisted cascade training | Arm Label: Specialist Arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Specialist led training in THP | Intervention Type: OTHER; Name: Avatar assisted cascade training; Assigned to Arm(s): Technology Arm | Intervention Type: OTHER; Name: Specialist led training in THP; Assigned to Arm(s): Specialist Arm
D: Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: Behavioral Activation; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Activation | Arm Label: non-specific counseling; Type: EXPERIMENTAL; Interventions: Behavioral: nonspecific counseling | Arm Label: wait control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Behavioral Activation; Assigned to Arm(s): Behavioral Activation | Intervention Type: BEHAVIORAL; Name: nonspecific counseling; Assigned to Arm(s): non-specific counseling

Answer: D